These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 3687295)
21. Studies on preparation of a tick-borne encephalitis (TBE) vaccine from the Skalica strain. Gresíková M; Sekeyová M; Marcinka K; Ciampor F Acta Virol; 1986 May; 30(3):243-8. PubMed ID: 2874729 [TBL] [Abstract][Full Text] [Related]
22. Preclinical investigations of the safety, immunogenicity and efficacy of a purified, inactivated tick-borne encephalitis vaccine. Klockmann U; Bock HL; Franke V; Hein B; Reiner G; Hilfenhaus J J Biol Stand; 1989 Oct; 17(4):331-42. PubMed ID: 2613707 [TBL] [Abstract][Full Text] [Related]
23. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes. Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771 [TBL] [Abstract][Full Text] [Related]
24. [Assessment of the immunologic effectiveness of a concentrated purified vaccine against tick-borne encephalitis in experiments on animals]. Korovina GI; Titova TS; Churnosov EV Tr Inst Im Pastera; 1989; 65():150-5. PubMed ID: 2629183 [No Abstract] [Full Text] [Related]
25. [A comparison of the immune response induced by DNA or by an inactivated vaccine against tick-borne encephalitis]. Morozova OV; Popova RV; Maksimova TG; Mitrofanova EE; Bakhvalova VN Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):54-7. PubMed ID: 10808575 [TBL] [Abstract][Full Text] [Related]
26. [Concentrated purified vaccine against tick-borne encephalitis prepared by means of zonal ultracentrifugation. Development of the preparation]. El'bert LB; Gagarina AV; Khanina MK; Krutianskaia GL; Grachev VP Vopr Virusol; 1980; (3):341-5. PubMed ID: 7434727 [TBL] [Abstract][Full Text] [Related]
27. Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine. Klockmann U; Krivanec K; Stephenson JR; Hilfenhaus J Vaccine; 1991 Mar; 9(3):210-2. PubMed ID: 2042394 [TBL] [Abstract][Full Text] [Related]
29. [Quantitative indices of the immune status of persons inoculated with different vaccines against tick-borne encephalitis]. Bukovskaia SN; Vorob'eva MS; Karpovich LG; Shalamberidze TD Vopr Virusol; 1983; 28(4):100-3. PubMed ID: 6636697 [TBL] [Abstract][Full Text] [Related]
30. [The possibility of preparing a live vaccine against tick-borne encephalitis from Malay langat virus TP-21]. Il'enko VI; Platonov VG; Prozorova IN; Smorodintsev AA Tr Inst Im Pastera; 1989; 65():126-32. PubMed ID: 2560847 [No Abstract] [Full Text] [Related]
31. Antigenic and immunogenic properties of defined physical forms of tick-borne encephalitis virus structural proteins. Heinz FX; Tuma W; Kunz C Infect Immun; 1981 Jul; 33(1):250-7. PubMed ID: 7263062 [TBL] [Abstract][Full Text] [Related]
32. Vaccination against tick-borne encephalitis--distant evaluation. Bobrowska E; Grzeszczuk A; Prokopowicz D Rocz Akad Med Bialymst; 1996; 41(1):44-50. PubMed ID: 8673804 [TBL] [Abstract][Full Text] [Related]
33. Generation and Characterization of a Chimeric Tick-Borne Encephalitis Virus Attenuated Strain ChinTBEV. Wang HJ; Li XF; Qin CF Methods Mol Biol; 2016; 1403():285-93. PubMed ID: 27076137 [TBL] [Abstract][Full Text] [Related]
35. [Immunoenzyme method in the diagnosis of tick-borne encephalitis]. Bashkirtsev VN; Ivanov AP; Dekonenko EP; Pivanova GP; Vorob'eva MS Vopr Virusol; 1986; 31(1):96-100. PubMed ID: 3515766 [TBL] [Abstract][Full Text] [Related]
36. [Immunoenzyme analysis with visual demonstration for detecting antibodies to the tick-borne encephalitis virus]. Mironova EB; Matveev LKh; Pressman EK; Ammosov AD Zh Mikrobiol Epidemiol Immunobiol; 1989 Jan; (1):54-7. PubMed ID: 2652955 [TBL] [Abstract][Full Text] [Related]
37. [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm]. Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP; Gorbunov MA; Pavlova LI; Bektimirov TA Vopr Virusol; 1996; 41(5):221-4. PubMed ID: 8967069 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus. Chidumayo NN; Yoshii K; Kariwa H Microbiol Immunol; 2014 Feb; 58(2):112-8. PubMed ID: 24329534 [TBL] [Abstract][Full Text] [Related]
39. [Immunological status of people inoculated with various types of inactivated vaccine against tick-borne encephalitis]. Pervikov IuV; El'bert LB; Krutianskaia GL; Belotskiĭ SM; Krasil'nikov IV Vopr Virusol; 1982; 27(6):696-701. PubMed ID: 7157778 [TBL] [Abstract][Full Text] [Related]
40. [Subunit immunogen of the tick-borne encephalitis virus. The immunological characteristics of glycoprotein V3 from 2 antigenic types of tick-borne encephalitis virus]. Chumakov MP; Rubin SG; Kusov IuIu; Semashko IV; Sal'nikov IaA Vopr Virusol; 1984; 29(6):701-6. PubMed ID: 6528577 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]